LYEL
Price
$9.75
Change
-$0.02 (-0.20%)
Updated
Jul 11 closing price
Capitalization
144.38M
25 days until earnings call
SANA
Price
$4.18
Change
+$0.13 (+3.21%)
Updated
Jul 11 closing price
Capitalization
942.82M
19 days until earnings call
Interact to see
Advertisement

LYEL vs SANA

Header iconLYEL vs SANA Comparison
Open Charts LYEL vs SANABanner chart's image
Lyell Immunopharma
Price$9.75
Change-$0.02 (-0.20%)
Volume$23.43K
Capitalization144.38M
Sana Biotechnology
Price$4.18
Change+$0.13 (+3.21%)
Volume$5.06M
Capitalization942.82M
LYEL vs SANA Comparison Chart in %
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. SANA commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and SANA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2025
Stock price -- (LYEL: $9.75 vs. SANA: $4.18)
Brand notoriety: LYEL and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 14% vs. SANA: 105%
Market capitalization -- LYEL: $144.38M vs. SANA: $942.82M
LYEL [@Biotechnology] is valued at $144.38M. SANA’s [@Biotechnology] market capitalization is $942.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 5 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • LYEL’s TA Score: 5 bullish, 4 bearish.
  • SANA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than SANA.

Price Growth

LYEL (@Biotechnology) experienced а +0.62% price change this week, while SANA (@Biotechnology) price change was +31.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.14%. For the same industry, the average monthly price growth was +16.46%, and the average quarterly price growth was +20.75%.

Reported Earning Dates

LYEL is expected to report earnings on Aug 06, 2025.

SANA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($943M) has a higher market cap than LYEL($144M). SANA YTD gains are higher at: 156.442 vs. LYEL (-23.828). SANA (-195.34M) and LYEL (-204.02M) have comparable annual earnings (EBITDA) . LYEL has more cash in the bank: 301M vs. SANA (105M). LYEL has less debt than SANA: LYEL (48.9M) vs SANA (91.3M). LYEL has higher revenues than SANA: LYEL (65K) vs SANA (0).
LYELSANALYEL / SANA
Capitalization144M943M15%
EBITDA-204.02M-195.34M104%
Gain YTD-23.828156.442-15%
P/E RatioN/AN/A-
Revenue65K0-
Total Cash301M105M287%
Total Debt48.9M91.3M54%
TECHNICAL ANALYSIS
Technical Analysis
LYELSANA
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSVRX43.10N/A
N/A
Columbia Small Cap Value I R
DILCX13.89N/A
N/A
Davis International C
GMNCX11.27N/A
N/A
Gabelli Global Mini Mites C
SCAVX14.56N/A
N/A
AB Small Cap Value A
MRGCX42.75-0.24
-0.56%
MFS Core Equity C

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-0.20%
VCYT - LYEL
46%
Loosely correlated
-1.60%
ZNTL - LYEL
42%
Loosely correlated
-2.92%
CRBU - LYEL
40%
Loosely correlated
-6.32%
BEAM - LYEL
39%
Loosely correlated
-3.95%
TYRA - LYEL
39%
Loosely correlated
+0.20%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with VIR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+3.21%
VIR - SANA
63%
Loosely correlated
-4.72%
CPRX - SANA
43%
Loosely correlated
-0.18%
AXON - SANA
43%
Loosely correlated
-0.46%
ABSI - SANA
40%
Loosely correlated
-2.20%
GBIO - SANA
39%
Loosely correlated
+3.62%
More